RocketTickers

RocketTickers

TCON: TRACON Pharmaceuticals, Inc. 2022-03-10 08:05:00 TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol

RocketTickers

LLY: Eli Lilly and Company 2022-02-24 16:00:00 US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction

RocketTickers

AQST: Aquestive Therapeutics, Inc. 2022-02-25 07:00:00 Aquestive Therapeutics Reports Positive Topline Data from Part 1 of EPIPHAST Trial Evaluating AQST-109 Epinephrine

RocketTickers

AQST: Aquestive Therapeutics, Inc. 2022-02-25 07:00:00 Aquestive Therapeutics Reports Positive Topline Data from Part 1 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film

RocketTickers

CERE: Cerevel Therapeutics Holdings, Inc. 2022-02-15 06:30:00 Cerevel Therapeutics Announces Positive Topline Results for Darigabat in Phase 1 Clinical Trial in Acute Anxiety

RocketTickers

CTXR: Citius Pharmaceuticals, Inc. 2022-02-15 09:15:00 Citius Pharmaceuticals Announces FDA Acceptance of IND Application for its Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids

RocketTickers

SCYX: Scynexis 2022-02-10 07:36:33 SCYNEXIS Announces Positive Results from Its Pivotal Phase 3 CANDLE Study of Oral Ibrexafungerp for Prevention of Recurrent Vaginal Yeast Infections, Clearing the Way for Regulatory Submission and Potential Approval of Additional Indication by End of 2022

RocketTickers

NGM: NGM Biopharmaceuticals, Inc. 2022-02-07 08:00:00 NGM Bio’s NGM621 Receives Fast Track Designation from the FDA for the Treatment of Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration

RocketTickers

TSHA: Taysha Gene Therapies, Inc. 2022-01-31 07:00:00 Taysha Gene Therapies Reports Positive Clinical Efficacy and Safety Data for High Dose Cohort and Long-term Durability Data for TSHA-120 in Giant Axonal Neuropathy

RocketTickers

ALT: Altimmune, Inc 2022-01-31 07:00:00 Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity

RocketTickers

TPTX: Turning Point Therapeutics, Inc 2022-01-20 09:00:00 Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Combination of Elzovantinib and Aumolertinib in EGFR Mutant Met-Amplified Non-Small Cell Lung Cancer

RocketTickers

CTMX: CytomX Therapeutics, Inc. 2022-01-19 08:00:00 CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for the Treatment of Advanced Solid Tumors

RocketTickers

ALDX: Aldeyra Therapeutics, Inc. 2022-01-11 08:00:00 Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigational New Drug, Compared to Xiidra®

RocketTickers

ATRS: Antares Pharma, Inc. 2022-01-11 07:30:00 Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue

RocketTickers

CARA: Cara Therapeutics, Inc. 2022-01-10 08:00:00 Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study in Japan for the Treatment of Pruritus in Hemodialysis Patients

RocketTickers

EWTX: Edgewise Therapeutics, Inc. 2022-01-05 08:00:00 Edgewise Therapeutics Announces Positive Topline Results From the EDG-5506 Phase 1b Clinical Trial in Adults With Becker Muscular Dystrophy (BMD)

RocketTickers

ABBV: AbbVie Inc. 2022-01-04 08:15:00 AbbVie Announces U.S. FDA Granted Breakthrough Therapy Designation (BTD) to Telisotuzumab Vedotin (Teliso-V) for Previously Treated Non-Small Cell Lung Cancer

RocketTickers

GNPX: Genprex, Inc. 2022-01-03 08:00:00 Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer